Vascular & Endovascular Highlights: The world's most expensive drug | A closer look at the BEST-CLI trial

News You Need to Know Today

Monday, December 12, 2022

Editor's Choice: Vascular & Endovascular

Treatments for rheumatoid arthritis, Parkinson’s disease linked to cardiovascular benefits

New research published in Annals of Rheumatic Diseases and Hypertension examined the impact medications for different non-cardiovascular conditions can have on a patient's heart health.

Treatments for rheumatoid arthritis, Parkinson’s disease linked to cardiovascular benefits

New research published in Annals of Rheumatic Diseases and Hypertension examined the impact medications for different non-cardiovascular conditions can have on a patient's heart health.

FDA approves world’s most expensive drug, a hemophilia B treatment expected to cost $3.5M

The single-dose gene therapy can help patients reduce their risk of bleeding events and discontinue factor IX prophylaxis therapy.

FDA approves world’s most expensive drug, a hemophilia B treatment expected to cost $3.5M

The single-dose gene therapy can help patients reduce their risk of bleeding events and discontinue factor IX prophylaxis therapy.

Seaweed molecules could lead to big improvements for heart surgery patients

“There is a crucial need to develop synthetic vascular graft materials that will increase the rate of long-term functions,” one researcher said. Could materials derived from seaweed help fill that need?

Seaweed molecules could lead to big improvements for heart surgery patients

VIDEO: Surgery vs. endovascular intervention for critical limb ischemia in the BEST-CLI trial

Watch our exclusive interview, recorded live at the AHA Scientific Sessions 2022 conference, with three investigators from the BEST-CLI trial.

Interview with the late-breaking BEST-CLI trial principal investigators Alik Farber from Boston Medical Center, Matthew Menard from Brigham and Women's Hospital, and Ken Rosenfield at Mass General Hospital, at the 2022 American Heart Association (AHA) meeting. The trial looked at endovascular versus bypass surgery in patients with critical limb ischemia (CLI) to see which is better. #AHA22

VIDEO: Surgery vs. endovascular intervention for critical limb ischemia in the BEST-CLI trial

Watch our exclusive interview, recorded live at the AHA Scientific Sessions 2022 conference, with three investigators from the BEST-CLI trial.

PHOTO GALLERY: AHA 2022

A photo essay from the American Heart Association (AHA) 2022 Scientific Sessions Nov. 5-7 in Chicago.

$Example of fractional flow reserve (FFR) calculated using AI and assessment of the plaque in the vessel on a CT scan of the coronaries. This new type of FFR-CT was shown as a work-in-progress by the vendor Elucid. It was shown for the first time at AHA 2022.$

PHOTO GALLERY: AHA 2022

A photo essay from the American Heart Association (AHA) 2022 Scientific Sessions Nov. 5-7 in Chicago.

In Case You Missed It

Drug-coated balloons an effective tool in the battle against femoropopliteal disease

Two late-breaking clinical trials presented at the VIVA Foundation’s VIVA22 conference in Las Vegas highlighted the impact drug-coated balloons can make on patient outcomes.

Drug-coated balloons an effective tool in the battle against femoropopliteal disease

Two late-breaking clinical trials presented at the VIVA Foundation’s VIVA22 conference in Las Vegas highlighted the impact drug-coated balloons can make on patient outcomes.

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us | Unsubscribe from all | Privacy Policy

© Innovate Healthcare, a TriMed Media brand

Editor's Choice: Vascular & Endovascular

In Case You Missed It

Recent Newsletters